Previous Article | Next Article 
Journal of Bacteriology, March 1999, p. 1664-1672, Vol. 181, No. 5
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Secretion, Localization, and Antibacterial Activity
of TasA, a Bacillus subtilis Spore-Associated
Protein
Axel G.
Stöver and
Adam
Driks*
Department of Microbiology and Immunology,
Loyola University Medical Center, Maywood, Illinois 60153
Received 2 October 1998/Accepted 22 December 1998
 |
ABSTRACT |
The synthesis and subcellular localization of the proteins that
comprise the Bacillus subtilis spore are under a variety of complex controls. To better understand these controls, we have identified and characterized a 31-kDa sporulation protein, called TasA,
which is secreted into the culture medium early in sporulation and is
also incorporated into the spore. TasA synthesis begins approximately
30 min after the onset of sporulation and requires the sporulation
transcription factor genes spo0H and spo0A. The first 81 nucleotides of tasA encode a 27-amino-acid
sequence that resembles a signal peptide and which is missing from TasA
isolated from a sporulating cell lysate. In B. subtilis
cells unable to synthesize the signal peptidase SipW, TasA is not
secreted, nor is it incorporated into spores. Cells unable to produce
SipW produce a 34-kDa form of TasA, consistent with a failure to remove
the N-terminal 27 amino acids. In cells engineered to express
sipW and tasA during exponential growth, TasA
migrates as a 31-kDa species and is secreted into the culture medium.
These results indicate that SipW plays a crucial role in the export of
TasA out of the cell and its incorporation into spores. Although TasA is dispensable for sporulation under laboratory conditions, we find
that TasA has a broad-spectrum antibacterial activity. We discuss the
possibility that during the beginning of sporulation as well as later,
during germination, TasA inhibits other organisms in the environment,
thus conferring a competitive advantage to the spore.
 |
INTRODUCTION |
In response to starvation,
Bacillus subtilis constructs a highly resistant endospore
during a process called sporulation (31). Soon after a cell
commits to sporulation, it builds an asymmetrically positioned septum
that divides the sporulating cell, called a sporangium, into two
unequally sized cells with distinct developmental fates. The smaller
chamber, called the forespore, ultimately becomes the spore. The larger
compartment, called the mother cell, nurtures the developing spore
during its formation. In the next stage of sporulation, the edge of the
septum migrates toward the forespore pole of the cell and engulfs the
smaller forespore compartment, resulting in a protoplast with two
membrane layers that is entirely surrounded by the mother cell. The
space between this double layer of membrane becomes the site of
assembly of two layers of specialized peptidoglycan called the germ
cell wall and the cortex. The last structure to be formed is a
proteinacious shell, called the coat, that encircles and protects the
spore. In its final act, the mother cell lyses, releasing the now
mature spore into the environment. A series of sequentially activated
transcription factors ensures that sporulation genes are activated at
the proper times and in the correct compartments. Prior to the
appearance of the sporulation septum, the transcription factors Spo0A
and
H direct the expression of a large group of genes
(10, 12). Once the septum is formed, sigma factors
F and
E become active in the forespore
and mother cell, respectively (20). After engulfment, the
activity of
F in the forespore is replaced by that of
G. Similarly, the activity of
E in the
mother cell is replaced by that of
K.
To better understand the mechanisms that guide sporulation proteins to
their correct sites during spore assembly, we began to identify novel
spore components and the mechanisms that control their subcellular
localization. Here, we describe an abundant component of mature spores
called TasA. We found that TasA synthesis occurs prior to the formation
of the sporulation septum and requires the transcription factors Spo0A
and
H. Immediately after synthesis, TasA is secreted
into the culture medium. Secretion appears to require the removal of
the N-terminal 27 amino acids (comprising an apparent signal peptide),
an event that depends on the signal peptidase SipW (32),
which is encoded immediately upstream of tasA. Strikingly,
the incorporation of TasA into the spore also depends on SipW. We
tentatively propose that after the sporulation septum is made, the same
secretory system that directs TasA into the medium also secretes TasA
into the space between the septal membranes, where it becomes trapped, ultimately becoming associated with the spore peptidoglycan and possibly with the coat. These results suggest that maturation of at
least one secreted sporulation protein requires SipW. SipW is not
absolutely required for sporulation, since deletion of sipW
(or tasA) does not have a strong effect on spore formation. However, in plate diffusion assays, TasA exhibits an antibacterial activity against a variety of gram-positive and gram-negative bacteria.
Therefore, we chose the name tasA to reflect our finding that this protein is a translocation-dependent antimicrobial spore component. We speculate that this activity provides the sporulating cell with a competitive advantage during the early stages of
development as well as providing protection during and after germination.
 |
MATERIALS AND METHODS |
Strains, plasmids, and recombinant DNA procedures.
Strains,
plasmids, and primers for the PCR used in this study are listed in
Tables 1 and
2. PCR products generated in this study
are illustrated in Fig. 2B. All B. subtilis strains are congenic with the wild-type strain PY79 (34), except for
RL102, which is congenic with strain 168 (Table 1). We used
Luria-Bertani medium (LB) for the routine growth of B. subtilis and Escherichia coli strains, Mueller-Hinton
medium for the growth of animal-pathogenic bacteria, and King's B
medium (16) for the growth of plant-pathogenic bacteria. We
performed recombinant DNA techniques as described previously
(28) and used E. coli DH5
as the host strain
for molecular cloning. We performed PCR as specified by the
instructions provided with the GeneAmp PCR core reagents
(Perkin-Elmer).
Manipulation of B. subtilis.
Genetic manipulation of
B. subtilis was carried out as described previously
(6). Strains bearing mutations in tasA,
sipW, or yqxM were generated by transformation of
competent cells of strain AD17, AD142, or PY79 with a DNA construct
bearing the appropriate mutation, described below. We induced
sporulation by nutrient exhaustion (29). We prepared free
spores after 48 h of culturing, by which time >95% of the cells
were spores. We performed the tetrazolium assay as described previously
(13).
Preparation and electrophoresis of spore extracts.
We
harvested spores by centrifugation, resuspended them in TBS (25 mM
Tris-HCl [pH 7.5], 135 mM NaCl, 2.7 mM KCl), and incubated the
suspension at 75°C for 10 min to reduce spore-associated protease activity. After heat treatment, we incubated the spores on ice for 5 min, pelleted them by centrifugation, washed the spore pellet once in
0.5 M NaCl, centrifuged the spores again, and then froze the pellet
until use. For electrophoresis, we loaded an amount of extract
corresponding to 2 ml of the original sporulating culture into each
well of a sodium dodecyl sulfate (SDS)-polyacrylamide gel.
Production of cotE
::cat
sporangial lysate.
We harvested
cotE
::cat sporangia (from AD28) by
centrifugation after 5 h of sporulation and washed the cells with
TBS. We resuspended the cells in TBS, incubated them with lysozyme (2 mg/ml) for 5 min on ice, and then lysed them by sonication with a
Fisher Dismembrator. We centrifuged the lysate for 10 min at 10,000 × g, filtered the supernatant through a
0.45-µm syringe filter, and froze it at
20°C until use. We then
thawed the supernatant on ice and centrifuged it for 15 min at
16,000 × g. We resuspended the pellet in loading
buffer and analyzed it by SDS-polyacrylamide gel electrophoresis (PAGE).
Production of cell lysates for Western blot analysis.
We
harvested vegetative cells (at an optical density at 600 nm
[OD600] of 0.7 to 0.9) and sporangia by centrifugation,
washed them once in TBS, and froze the pellet until use. To lyse the cells, we resuspended the pellet in 75 µl of GTE (25 mM Tris-HCl [pH
7.5], 50 mM glucose, 10 mM EDTA), added lysozyme to a final concentration of 2 mg/ml, and incubated the suspension at room temperature for 5 min. We then added 25 µl of 4× loading buffer including dithiothreitol (28), and immediately boiled the
samples for 5 min. The cells appeared completely lysed by light
microscopy. For Western blot analysis, we centrifuged the samples for 5 min and added an amount of lysate corresponding to 0.4 OD600 unit of the original culture to each well of an
SDS-polyacrylamide gel.
SDS-PAGE and Western blotting.
SDS-PAGE and Western blotting
were performed as described previously (28). We transferred
the proteins to a polyvinylidene difluoride membrane (Immobilon;
Millipore) at constant voltage of 35 V for at least 4 h. We used
the anti-TasA antiserum at a 1:5,000 to 1:10,000 dilution. After
treatment with anti-TasA antibodies, we incubated the membrane with
alkaline-phosphatase-conjugated secondary antibodies (Promega) and then
with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate
(Gibco-BRL) as specified by the manufacturers.
Polyclonal antiserum.
To prepare TasA as an immunogen,
we thawed an aliquot of sporangial lysate (see above) on ice and
centrifuged it for 15 min at 14,000 × g. We
resuspended the pellet in loading buffer and fractionated it by
SDS-PAGE. We isolated the 31-kDa band from the polyacrylamide gel
(11) and injected approximately 100 µg of this material
intramuscularly and subcutaneously into a rabbit. We prepared antiserum
from blood obtained 23 days after injection.
Amino acid sequencing.
We subjected a sporangial lysate (see
above) to SDS-PAGE, transferred the protein in the gel to a
polyvinylidene difluoride membrane (Immobilon) in CAPS buffer
(22), stained the membrane with Coomassie brilliant blue to
identify the 31-kDa band, and then destained the membrane. We then cut
out a slice of the membrane containing the 31-kDa band and had
Edman-degradation sequencing performed on the membrane-bound protein by
B.-S. Lee at the Protein Research Laboratory, University of Illinois,
Chicago, Ill.
Protein isolation from culture supernatants.
Sporulating
cells were harvested after 2 h of sporulation unless otherwise
noted, and vegetatively growing cells were collected at an
OD600 of 0.7 to 0.9. We centrifuged the cell suspension for
5 min at 16,000 × g and filtered the supernatant
through a 0.45-µm syringe filter. To precipitate proteins, we added 1 volume of supernatant to 9 volumes of absolute ethanol and incubated the mixture at
70°C overnight. We then centrifuged the sample at
14,000 × g for 10 min at 4°C, washed the pellet once
with 80% ethanol, and completely dried it in a Speed-Vac concentrator
(Savant) for 20 min. We electrophoresed the precipitated supernatant of 200 µl of culture in each well of a SDS-polyacrylamide gel.
Generation of deletion mutations in tasA.
We generated
two deletions of tasA: one by a single-reciprocal
integration (Campbell type) into the genome of a plasmid bearing an
internal region of tasA (by using pAGS08) and the other by marker replacement of part of the genomic copy of tasA with
a spectinomycin resistance gene (by using pAGS18b). We confirmed integration by PCR (data not shown).
First, we placed the spectinomycin resistance gene of pJL74 (in a
BamHI-EcoRV fragment) into pSL1180 (Pharmacia),
liberated it by digestion with SphI and BamHI,
and cloned it into pET24b (Novagen) cut with SphI and
BglII, resulting in pAGS05. We PCR amplified the chromosomal
locus encompassing tasA with primers OL58 and OL59 (see Fig.
2B), cloned it into NdeI- and XhoI-digested pAGS05, and cut the resulting plasmid with EcoRI and
HindIII to release a fragment of the tasA
open reading frame (see Fig. 2B). We cloned this fragment between the
EcoRI and HindIII sites of pJL74. The
resulting plasmid, pAGS08, was used to transform competent cells.
Transformants were selected for resistance to spectinomycin.
To generate pAGS18b, we amplified the tasA locus by PCR with
primers OL74 and OL75 (see Fig. 2B), digested the PCR product with
XhoI and HaeIII, and cloned it between the
XhoI and EcoRV sites in pET24b. We digested this
plasmid with EcoRI and HindIII, used the
Klenow fragment to generate blunt termini, and cloned the spectinomycin
cassette (inserted into pSL1180 and then liberated with
EcoRV and SmaI) into this vector. The resulting
plasmid, pAGS18b, was linearized with PvuI and used to
transform competent cells to spectinomycin resistance.
Generation of deletion mutations in sipW.
First, we
amplified the sipW gene by PCR with primers OL76 and OL77
(see Fig. 2B). We digested the product with XhoI and
ClaI and cloned it into XhoI- and
ClaI-digested pJL74. We removed a 141-bp region of the
sipW open reading frame with NdeI and
BstEII, generated blunt termini with Klenow fragment, and
replaced the region with a neomycin resistance gene (recovered from
pBEST501 [14] with SmaI). This resulted in
pAGS17-1, in which the orientation of the neomycin gene-bearing insert
is opposite to the orientation of sipW, and in pAGS17-2, in
which the orientation of the drug resistance cassette is identical to
the orientation of sipW. We linearized these plasmids with
PvuI, used them to transform competent cells, and selected
transformants with 3.5 µg of neomycin per ml. We used PCR
amplification to confirm genomic integration by marker replacement and
the orientations of the drug resistance cassette (data not shown).
Generation of an insertional mutation in yqxM.
First,
we used PCR and oligonucleotides OL72 and OL77 to amplify
yqxM and sipW (see Fig. 2B), digested the PCR
product with XhoI and BstEII, and cloned it into
similarly digested pET24b to generate pAGS21. We cut pAGS21 with
HindIII, filled the overhangs with Klenow fragment, and
inserted the neomycin resistance gene (see above), generating pAGS22.
By PCR, we determined that the orientation of the neomycin resistance
gene is the same as the putative direction of transcription of
yqxM (data not shown). We amplified the yqxM open
reading frame sequences flanking the inserted neomycin gene with
oligonucleotides OL72 and OL77 and transformed competent cells with the
PCR product. We confirmed by PCR that marker replacement had occurred
(data not shown).
Overproduction of YqxM and TasA.
To insert yqxM
or tasA into pAGS05 (described above), we performed PCR with
primer pairs OL99 and OL91 or OL93 and OL94, respectively (see Fig.
2B). This amplified either the entire yqxM coding sequence or a portion of tasA corresponding to amino acid residues 28 through 260, resulting in a truncated version of tasA
missing the sequence encoding the putative signal peptide. We digested
the PCR products with XhoI and NdeI and ligated
them to similarly digested pAGS05. This resulted in pAGS41, harboring
the in-frame insertion of the yqxM open reading frame, or
pAGS37, bearing the tasA fragment downstream of a
translational start codon and upstream of a gene segment encoding six
histidines. We then transformed E. coli BL21(DE3) with
pAGS37 or pAGS41 as well as with the empty plasmid (pAGS05) and used
these strains to inoculate 5 ml of LB supplemented with 30 µg of
kanamycin per ml and incubated the cultures with shaking at 30°C
overnight. The next day, we inoculated 50 ml of LB, supplemented with
30 µg of kanamycin per ml, with 2 ml of the overnight culture and
grew the cells at 37°C. When the OD600 of the cultures
reached 0.5 to 0.8, we added
isopropyl-
-D-thiogalactopyranoside (IPTG; Gibco) to a
final concentration of 1 mM. We continued incubation for 6 to 7 h,
harvested the cell pellets by centrifugation at 6,000 × g for 10 min at 4°C, and then resuspended the pellets in 10 ml
of TEN (10 mM Tris-HCl [pH 8.0], 100 mM NaCl, 1 mM EDTA). We measured
the OD600 of the cell suspensions (so that equivalent amounts of overproducing lysate and control lysate could be compared in
the antibacterial activity test), centrifuged the sample again, and
froze the cell pellet at
20°C until use. For the antibacterial activity assay (see below), we resuspended equivalent OD600
units of the overproducing cells and cells bearing the empty vector in
approximately 10 ml of TENT (TEN, 0.25% Triton X-100) and passed the
samples twice through a French press at 20,000 lb/in2 to
break the cells. We found that more than 99% of the cells had lysed
under these conditions as judged by light microscopy. We used SDS-PAGE
to verify the presence of overproduced YqxM or TasA in these lysates
(data not shown).
Testing for antibacterial activity.
Animal-pathogenic
bacteria and guidelines on testing were kindly provided by R. Carey,
Clinical Microbiology Laboratory, Loyola University Medical Center.
Plant-pathogenic bacteria were kindly provided by J. Greenberg,
University of Chicago. To test bacteria for sensitivity to TasA, we
first spread bacteria on agar medium plates. For plant-pathogenic
strains (see Table 3), we resuspended a colony (grown on solid King's
B medium) in liquid King's B medium and spread cells on solid King's
B medium with a cotton swab. For animal-pathogenic strains, we
resuspended 0.5 MacFarland unit of culture in saline and streaked the
cells on Mueller-Hinton plates with a cotton swab. Next, we used a
12-mm-diameter cork borer to punch two holes into the plates and
removed the agar discs. To each well, we added 400 µl of crude
E. coli lysates, prepared from strains harboring either the
tasA overexpression plasmid (pAGS37) or the empty vector
(pAGS05), and then incubated the plates. We grew the animal pathogens
(see Table 3) at 37°C (with the exception of Micrococcus
luteus, which we grew at 25°C) and the plant pathogens at
30°C. After incubation for 16 to 24 h, the diameters of the
zones of clearing were measured. Each experiment was carried out at
least twice, with similar results.
To test for TasA activity during coculturing, we inoculated 2.5 ml of
DSM medium to an OD600 of 0.1 with AGS175 or AGS157 and to
an OD600 of 0.005 with either Enterobacter
aerogenes (W31851-1) or Pseudomonas aeruginosa
(S77551-1). After 16 h, we removed an aliquot of culture and
plated it on MLS plates (6) (which killed B. subtilis but not the other strains) to determine the number of
CFU. To calculate the percent survival, we divided the number of
survivors after coculturing with AGS175 by the number of survivors after coculturing with AGS157 and multiplying by 100. Each percentage is the average of the results of two experiments. To measure the percent survival of B. subtilis, we incubated the culture
for 48 h (so that spores would be produced), heat treated it to
kill vegetative cells, and determined the number of CFU on LB plates.
 |
RESULTS |
Identification of a spore-associated protein and its gene.
To
identify novel spore-associated proteins, we carried out SDS-PAGE
analysis of proteins extracted from spores by boiling in the presence
of SDS and dithiothreitol. To focus our search toward novel proteins,
we analyzed spores missing most or all of the coat and hence missing
most of the already characterized abundant coat proteins. We examined
spores bearing a mutation in gerE (from AD17, in which the
inner coat and much of the outer coat are missing [8,
23]), in cotE (from AD28, in which the outer coat
is absent [35]), or in both genes (from AD142, in which both coat layers are lacking [8]). We identified
a 31-kDa species that is present in large amounts in spores from either a cotE
::cat gerE36 or a
gerE36 strain (Fig. 1A, lanes
1 and 2). We detected much smaller amounts of this protein in spores
from a cotE
::cat strain or from
wild-type spores (lanes 3 and 4). We also detected a 31-kDa band in a
lysate of cotE
::cat sporangia, harvested at stage 5 of sporulation (when cortex formation was complete), from which spores and cell debris had been removed by
centrifugation (Fig. 1B), indicating the presence of a
non-spore-associated protein with a similar molecular mass.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE analysis (15% polyacrylamide gel) of proteins
extracted from wild-type and mutant spores. (A) Lanes: 1, cotE ::cat gerE36; 2, gerE36; 3, cotE ::cat; 4, wild type (WT); 5, empty lane; 6, gerE36
tasA pAGS08. (B) Lysate of
cotE ::cat sporangia (sprng) 5 h
after initiation of sporulation. The arrowhead indicates the 40-kDa
species. The arrows indicate the position of TasA. Molecular masses are
indicated in kilodaltons.
|
|
To identify the gene that encodes the 31-kDa protein, we isolated the
31-kDa protein from a sporangial lysate (Fig. 1B), carried out Edman
degradation sequencing, and determined the sequence of the nine
N-terminal amino acids to be NH2-AFNDIKSKD-COOH (heavily underlined in Fig. 2A). A search of the
B. subtilis genome (17) revealed a perfect match
of this amino acid sequence to residues 28 to 36 encoded by the
putative open reading frame cotN (referred to as
yqhF in previous versions of the database), encoding a
hypothetical protein of 28,153.9 Da (composed of 261 amino acid
residues), which we renamed tasA. tasA is located downstream
from two other open reading frames, sipW and yqxM
(Fig. 2B). This locus is located at 218.1° on the chromosome, between
the comC locus (which encodes proteins required for
competence [9]) and the sin locus (encoding proteins that govern alternate developmental pathways
[1]). tasA and yqxM do not
exhibit significant homology to other genes in the databases.
sipW, however, is known to encode a signal peptidase (32).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
(A) N terminus of TasA. The putative signal peptide and
the N terminus of the mature protein are indicated. Sequence features
consistent with a signal peptide are indicated: three positively
charged lysines (bold) close to the N terminus, followed by a stretch
of hydrophobic amino acids (underlined) and a glycine residue (italic
and bold) 5 amino acids before the possible signal peptidase cleavage
site. The two alanines (one at the C terminus of the putative signal
peptide, and the other at the N terminus of the mature protein),
consistent with a signal peptidase cleavage site, are bold. The
sequenced region of the mature protein is heavily underlined. (B)
tasA locus. yqxM, sipW, and
tasA are indicated by boxes. The solid portions of the boxes
encode putative signal peptides. The arrows in the boxes indicate the
presumed direction of transcription. The brackets represent the PCR
products used in constructing mutations in the locus and for
overexpression. The oligonucleotides (Table 2) used to generate each
PCR product are indicated. The triangles indicate the disruptions of
yqxM and sipW by insertion of the neomycin
resistance gene cassette. The arrows above the triangles indicate the
directions of transcription of the neomycin resistance genes.
Restriction enzyme recognition sites are indicated: B2,
BstEII; RI, EcoRI; Ha3, HaeIII; H3,
HindIII; NI, NdeI.
|
|
To confirm that tasA encodes the 31-kDa protein and to
determine if the spore-associated and non-spore-associated proteins are
products of the same gene, we constructed a tasA deletion strain and generated a rabbit polyclonal antiserum against the non-spore-associated 31-kDa protein (Fig. 1B). In Western blot analysis, this antiserum reacted with both the 31-kDa band extracted from spores (Fig. 3A, lanes 1 through 4)
and the band from a lysate cleared of spores by centrifugation (Fig.
3B). We did not detect the 31-kDa band when we used the preimmune serum
(data not shown) or when we applied the postimmune serum to a spore
extract prepared from a gerE36 tasA
pAGS08
strain (AGS127) (Fig. 3A, lane 6). Sporangia and, to a much lesser
extent, spores contained a cross-reacting species of about 55 kDa (Fig.
3B) that was present in an extract of tasA cells and
therefore was not due to TasA (data not shown). We infer that the
spore-associated and non-spore-associated 31-kDa proteins are products
of a single gene. However, the two proteins are probably not
biochemically identical, since we were unable to sequence the
spore-associated protein, suggesting that the spore-associated species
might possess a posttranslational modification at its N terminus that
interferes with Edman degradation sequencing.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 3.
Western blot analysis (SDS-15% polyacrylamide gel) of
TasA extracted from spores or a sporangial lysate. (A) Extracts of
spores. Lanes: 1, cotE ::cat gerE36;
2, gerE36; 3, cotE ::cat;
4, wild type (WT); 5, empty lane; 6, gerE36
tasA pAGS08 (6). (B) Lysate of
cotE ::cat sporangia (sprng) 5 h
after initiation of sporulation. The arrows indicate the positions of
TasA. Molecular masses are indicated in kilodaltons.
|
|
We also used SDS-PAGE to analyze proteins extracted from
tasA spores. In otherwise wild-type spores, the polypeptide
profile was indistinguishable from that of the wild type (data not
shown). Because TasA is more readily detected in a gerE36
background, we analyzed gerE36 tasA
pAGS08
spores. As expected, these spores lack the 31-kDa band (Fig. 1A, lane
6). In addition, several bands seen in the wild type were not apparent
in the tasA mutant and a number of previously undetected
bands were present, including a band of unknown identity of
approximately 40 kDa (Fig. 1A, compare lanes 2 and 6).
Timing of TasA synthesis and transcription factor dependency.
To determine when TasA is synthesized, we measured the steady-state
levels of TasA by Western blot analysis in
cotE
::cat gerE36 cells (to permit
easier detection of TasA) cultured in Difco sporulation medium. We did
not detect any TasA until about 30 min after the initiation of
sporulation (Fig. 4, lanes 2 to 4), and
the signal reached a maximum at about 1.5 h (lane 6). TasA
remained at approximately this level until at least 12 h after
initiation (Fig. 4 and data not shown). We also investigated whether
known sporulation transcription factors are required for the appearance
of TasA. To do this, we prepared lysates of sporulating cells, bearing
a mutation in spo0A or one of the five known sporulation sigma factor genes, at a time in development when the transcription factor would be active and tested these lysates for the presence of
TasA by Western blot analysis. We examined strains mutated in the genes
encoding Spo0A (from RL891, after 1 h of sporulation),
H (from RL102, after 1 h),
F
(SC1159, after 2.5 h),
E (from PM806, after
2.5 h), or
G (from SC500, after 4.5 h) or in
an operon required for the activation of
K
(spoIVF) (from SAB50, after 4.5 h). We detected TasA in
all lysates (Fig. 5, lanes 3 through 6)
except those from spo0A::erm or
spo0H
HindIII-EcoRI::cat cells (lanes 1 and 2, respectively).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 4.
Western blot analysis (SDS-15% polyacrylamide gel) of
TasA steady-state levels. Lane 1 contains an extract of
cotE ::cat gerE36 spores (to indicate
the position of TasA). Extracts were prepared 30 min before sporulation
(lane 2) and at 30-min intervals until the second hour of sporulation
(lanes 3 to 7) and then at 1-h intervals (lanes 8 and 9). The arrow
indicates the position of TasA. The numbers above the blot indicate the
time at which the samples were prepared, relative to the beginning of
sporulation. Molecular masses are indicated in kilodaltons.
|
|

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 5.
Western blot analysis (SDS-15% polyacrylamide gel) of
TasA in transcription factor mutant strains. Lanes 1 to 6 contain
extracts from sporangia with the mutations
spo0A ::erm (lane 1),
spo0H HindIII-EcoRI::cat
trpC2 (lane 2), spoIIAC1 (lane 3),
spoIIGA 17 (lane 4), spoIIIG 1 (lane 5), or
spoIVF AB::cat (lane 6). The
transcription factors which are inactive in each strain are indicated
above each lane. The arrow indicates the position of TasA. Molecular
masses are indicated in kilodaltons.
|
|
Role of secretion in the localization of TasA.
The sequence of
the N terminus of TasA (AFNDIKSKD) does not correspond to the N
terminus of the predicted product of tasA but, rather,
starts at amino acid residue 28 (Fig. 2A). This discrepancy would be
accounted for if TasA were posttranslationally processed. We found that
the 27 amino-terminal residues of the predicted gene product contain
structural features characteristic of a B. subtilis signal
peptide. These include three positively charged amino acids toward the
N terminus of the peptide, followed by a core region composed primarily
of hydrophobic amino acids and a glycine residue 5 amino acids before
the putative signal peptidase cleavage site (30) (Fig. 2A).
Furthermore, the last residue of the putative signal peptide and the
first residue of the mature protein are alanines, also characteristic
of a B. subtilis signal peptidase cleavage site
(24). These observations point to the possibility that TasA
is secreted by a signal peptidase-dependent mechanism (25).
We suspect that both the spore-associated and the non-spore-associated
forms of TasA are similarly processed, since they both migrated as
31-kDa species in SDS-PAGE (Fig. 1A, lanes 1 and 2; Fig. 1B).
If TasA is processed and secreted, it should be translocated across the
cytoplasmic membrane and perhaps into the culture supernatant. To test
this, we centrifuged a sporulating culture 2 h after the onset of
sporulation (when TasA is present [Fig. 4, lane 7]), concentrated the
proteins in the supernatant by ethanol precipitation, and then probed
for TasA by Western blot analysis. We identified TasA in supernatants
of sporangia of wild-type and cotE
::cat gerE36 strains (Fig.
6, lanes 3 and 7; lanes 2 and 6 show the
position of TasA in sporangial lysates of the two strains, for
comparison). We did not detect any signal in culture supernatants or
sporangia of tasA
::spc (from AGS207)
or cotE
::cat gerE36 tasA
::spc cells (from AGS210) (lanes
4, 5, 8, and 9).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
Western blot (SDS-15% polyacrylamide gel) of TasA in
sporangial lysates and culture supernatants. Lane 1 contains an extract
of cotE ::cat gerE36 spores (to
indicate the position of TasA). Lanes 2, 4, 6, and 8 contain lysates of
sporangia of a wild-type (WT) (lane 2),
tasA ::spc (lane 4),
cotE ::cat gerE36 (lane 6), or
cotE ::cat gerE36
tasA ::spc (lane 8) strain. Lanes 3, 5, 7, and 9 contain preparations of supernatants of wild-type (lane 3),
tasA ::spc (lane 5),
cotE ::cat gerE36 (lane 7), or
cotE ::cat gerE36
tasA ::spc (lane 9) cells. The arrow
indicates the position of TasA. sprng, sporangia; sup, supernatant.
Molecular masses are indicated in kilodaltons.
|
|
If mature TasA is the result of signal peptide cleavage, there should
be a signal peptidase that carries out this proteolytic event. One
candidate is the product of sipW (32, 33),
located immediately upstream of tasA (Fig. 2B). To test the
involvement of sipW in TasA maturation, we generated a
strain in which sipW was rendered nonfunctional, in a manner
that would not prevent tasA expression. To build this
strain, we deleted a portion of the sipW open reading frame
and inserted in its place a neomycin resistance gene (14)
oriented such that the constitutively active repU promoter
of the resistance gene would direct tasA gene expression during sporulation as well as vegetative growth (Fig. 2B). We then used
Western blotting to analyze lysates of vegetative cells, sporulating
cells, or spores bearing these mutations as well as cotE
::cat and gerE36 (to
permit easier detection of TasA). We detected a 34-kDa form of TasA in
lysates of whole sporangia (Fig. 7A, lane
4). This molecular mass is consistent with that of an immature pre-form
of TasA. We did not find any TasA in extracts of spores (lane 6) or in
culture supernatants of sporulating cells bearing this construct (lane
5). We also detected the 34-kDa band in vegetative-cell lysates (lane
2), presumably as a result of the constitutively active
repU promoter, but not in vegetative-cell supernatants from
this strain (lane 3). Additionally, we constructed a strain in which
the neomycin resistance gene was oriented away from tasA
(Fig. 2B). In these cells, we did not detect TasA, in either spores or
sporulating cells (Fig. 7B, lanes 1 and 2). These results indicate that
the maturation of TasA requires SipW. Furthermore, they suggest that
the association of TasA with the spore and its export into the culture
medium depend on a secretory event that requires SipW. We also found a
band representing a protein of 29 kDa in lysates of vegetative cells
and sporangia (Fig. 7A, lanes 2 and 4) but not in spores (lane 6) or
supernatants (lanes 3 and 5). We assume that this signal corresponds to
a degradation product of TasA.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 7.
Western blot analysis (SDS-22% polyacrylamide gel) of
TasA in the lysate of sporangia, vegetatively growing cells, and
extracts of spores of cotE ::cat
gerE36 sipW ::neo strains. (A)
Lane 1 contains an extract of
cotE ::cat gerE36 spores (to
indicate the position of TasA). Lanes 2 through 6 contain preparations
of vegetative cells (lane 2), vegetative-cell supernatant (lane 3),
sporangia (lane 4), sporangial supernatant (lane 5), or spores (lane 6)
from AGS215, in which the direction of transcription of the neomycin
resistance gene is aligned with that of sipW. (B) Lanes 1 and 2 contain extracts of spores (lane 1) or sporangia (lane 2) of
AGS186, bearing the neomycin resistance gene with the opposite
orientation relative to the direction of transcription of
sipW. Lane 3 contains an extract of
cotE ::cat gerE36 spores (to indicate
the position of TasA). The arrows at the side of the blot indicate the
positions of TasA and pre-TasA. The arrowhead indicates the position of
the putative breakdown product of TasA. sprng, sporangia; sup,
supernatant; veg, vegetative. Molecular masses are indicated in
kilodaltons.
|
|
If the maturation of TasA depends on SipW, the placement of the
neomycin resistance gene upstream of sipW should permit the maturation and translocation of TasA. To test this, we inserted the
neomycin resistance gene into yqxM, oriented to direct the expression of both sipW and tasA (Fig. 2B). We
then used Western blot analysis to determine if cells of this strain
produced mature TasA during sporulation and vegetative growth. Using
the cotE
::cat gerE36 background, we
identified a band corresponding to mature TasA (31 kDa) in lysates of
sporangia (Fig. 8, lane 4), extracts of
spores (lane 6), and culture supernatants of sporulating cells after
2 h (lane 5) and 48 h (lane 7) of sporulation. We did not detect the immature form of TasA. We also detected mature TasA in
lysates and culture supernatants of vegetative cells (lanes 2 and 3).
This suggests that the expression of sipW and
tasA during vegetative growth is sufficient for the removal
of the signal peptide and the subsequent incorporation of TasA into the
spore and its secretion into the culture medium.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 8.
Western blot analysis (SDS-22% polyacrylamide gel) of
TasA in preparations of sporangia, exponentially growing cells, spores,
and supernatant of a cotE ::cat
gerE36 yqxM::neo strain (from
AGS185). Lanes 1 and 8 contain extracts of
cotE ::cat gerE36 spores (to indicate
the position of TasA). Lanes 2 and 3 contain extracts (lane 2) and
supernatant (lane 3) of vegetative cells. Lanes 4 and 5 contain
extracts of sporangia (lane 4) and supernatant of sporulating cells
(lane 5) at 2 h after initiation of sporulation. Lanes 6 and 7 contain extracts of spores (lane 6) and supernatants of sporulating
cultures (lane 7) at 48 h after initiation of sporulation. Lane 9 contains an extract of cotE ::cat
gerE36 sipW ::neo sporangia (to
indicate the position of pre-TasA). The arrows at the side of the blot
indicate the positions of TasA and pre-TasA. The arrowhead indicates
the position of the putative breakdown product of TasA. sprng,
sporangia; sup, supernatant; veg, vegetative. Molecular masses are
indicated in kilodaltons.
|
|
Role of TasA.
To learn the function of TasA, we examined
mutant cells and spores by microscopy and tested their resistance
properties. tasA
::spc cells showed
no significant defect in vegetative growth and sporulated at a normal
frequency as judged by light microscopy (data not shown). The spores
also appeared normal by both light and electron microscopy and had
wild-type levels of resistance to heat, chloroform, and lysozyme,
indicating no readily detectable role for tasA in spore
resistance (data not shown). However, these spores did exhibit a slight
germination defect as judged by the tetrazolium overlay assay (data not
shown), which measures the resumption of metabolism after germination.
Wild-type spores produce a red color in this assay, whereas spores that
are severely deficient in germination, e.g., gerE36,
generate a white color. tasA
::spc
spores produced a red color that was significantly lighter than the
color for the wild-type spores but clearly darker than that for a
typical germination mutant. It is possible, therefore, that TasA plays a role in germination. sipW
::neo
(from AGS157) and yqxM::neo tasA
pAGS08 (from AGS219) spores had largely the same phenotypes as tasA
::spc spores in all the
assays described above (data not shown). In contrast,
yqxM::neo (from AGS175) spores did
not show a germination phenotype by the tetrazolium assay (data not shown).
To identify a function for TasA, we decided to test for an activity
consistent with its production and secretion during a protective
response, such as sporulation, and for which a simple assay existed.
Therefore, we carried out a preliminary test for antibiotic or
antibacterial activity by using a variant of the disk diffusion assay
(19). We spread cells from one of a variety of strains
(Table 3) on an agar plate and cut two
wells into the plate. Into one, we placed a crude lysate of E. coli cells engineered to overproduce a form of TasA beginning with
amino acid 28. Into the other, we placed a crude lysate of the same E. coli strain bearing a version of the overexpression
plasmid that does not harbor the tasA gene. After overnight
growth of the cells, we measured the clear zones surrounding the wells. This experiment revealed that TasA can kill or inhibit the growth of a
variety of unrelated plant and animal pathogens. For example, we found
that the plant pathogen Agrobacterium tumefaciens GV3101 is
sensitive to TasA (having a zone diameter of 22 mm, compared with a
diameter of 12 mm for the well containing the E. coli lysate alone) whereas Pseudomonas aeruginosa is resistant to TasA
(with a zone diameter of 12 mm in both wells) (Table 3). Erwinia
amylovara EG321 was also sensitive but exhibited two distinct
concentric zones of clearing around the well. The inner zone (21 mm in
diameter) was completely clear, whereas the outer zone (33 mm in
diameter) exhibited very faint growth compared to the remainder of the
growth area of the plate. We also found that a variety of animal
pathogens, including clinical isolates of human pathogens, were
sensitive to TasA. Intriguingly, we found that the strain used to
overproduce TasA, E. coli BL21(DE3), and wild-type
B. subtilis (PY79), when grown vegetatively, were sensitive
to TasA. To learn whether YqxM possesses an antibacterial activity, we
tested its effect on the plant pathogens listed in Table 3. We did not
detect any antibacterial activity in our diffusion assay (data not
shown). This indicates that the antibacterial activity seen with TasA
is not a nonspecific effect of the overproduction of an ectopic
histidine-tagged protein.
To confirm that the antibacterial activity of TasA is not necessarily
due to a factor in the E. coli extract, we cocultured AGS175
(in which TasA is constitutively synthesized) or AGS157 (which cannot
secrete TasA) with E. aerogenes (W31851-1) or P. aeruginosa (S77551-1) and determined the percent survival of each species. We found that B. subtilis producing TasA reduced
the survival of E. aerogenes to 18.5%, which we interpret
as indicative of sensitivity. In contrast, P. aeruginosa
showed no reduction in survival, indicating resistance. The number of
surviving B. subtilis spores was unaffected by the secretion
of TasA or the presence of the other bacteria in the coculture
experiment (data not shown). These results indicate that the toxic
effect of TasA can occur in the absence of the E. coli extract.
 |
DISCUSSION |
We have identified a novel spore-associated protein, called TasA,
that is also present in the cell culture fluid. Two sets of results
suggest that TasA is a secreted protein. First, we were able to detect
TasA in the cell culture supernatant. Second, the difference in the
molecular masses of the translocated and nontranslocated species and
our sequence analysis of the N terminus of secreted TasA are consistent
with the possibility that a signal peptide is removed during or after
translocation. Our finding that the processing and export of TasA
depend on sipW suggests that TasA requires the signal
peptidase SipW, directly or indirectly, for the removal of the
N-terminal 27 amino acids. Two observations raise the possibility that
the spore-associated TasA is translocated across a membrane, similarly
to TasA found in the culture medium. First, TasA has the same mobility
on SDS-PAGE whether it is extracted from spores or purified from
culture supernatants. Second, localization to the spore requires
sipW. Although we do not know the location of TasA within
spores, it is likely to be underneath the coat (in the area of the
spore peptidoglycan) or at an interior location within the coat, since
we found that TasA was more readily extracted from spores in which most
or all of the coat was missing (due to mutations in gerE or
gerE and cotE).
The apparent interior location of TasA and the inferred role of SipW
are consistent with a speculative model in which secretion plays a
direct role in the localization of TasA (Fig.
9). In this view, TasA (Fig. 9A) is
synthesized under the control of
H and Spo0A in the
preseptation sporangium and is processed by SipW and secreted across
the cytoplasmic membrane via the general secretory pathway. Some TasA
is likely to be retained in the cell envelope and presumably is the
source of the non-spore-associated TasA identified in sporangial cell
lysates. Because we did not detect immature TasA (except in
sipW mutant cells), we infer that most TasA is translocated
very soon after synthesis. After the septum is built, essentially the
same secretory mechanism translocates TasA across one or both septal
membranes into the intermembrane space (Fig. 9B). TasA is likely to
remain trapped between the spore membrane layers for the duration of
sporulation (7). Because TasA appears to be translocated
immediately after synthesis, most TasA that is transported into the
septum would probably have been synthesized after septum formation. We
do not know what factors direct TasA synthesis at this time or whether
it occurs in one or both compartments. After engulfment, TasA probably
becomes associated with the spore peptidoglycan (Fig. 9C), where it may play a role in germination. The coat then assembles around the spore
and, therefore, over the location of TasA (Fig. 9D). This model does
not exclude the possibility that TasA is present in the coat as well as
residing at a more interior location. Possibly, TasA is relocated to
the coat during coat assembly but was not readily extracted in our
experiments. Alternatively, TasA present in the culture supernatant
could associate with spores after mother cell lysis. We are currently
testing the latter possibility. In preliminary experiments, we found
TasA associated with germinated spores up to 2 h after the
initiation of germination (data not shown). This could have been due to
TasA present in the spore cell wall prior to germination or to TasA
from the culture supernatant that bound to the germinated spore.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 9.
Model of the synthesis, processing, and translocation of
TasA. (A) A cell that has committed to sporulation. (B) The same cell
after the formation of the sporulation septum. (C) The same cell after
engulfment of the forespore. (D) The mature spore, released after
mother cell lysis. The hatched layer indicates the spore peptidoglycan,
and the black layer indicates the coat. See Discussion for a detailed
description. Solid rectangles, TasA; solid circles, secreted TasA;
shaded area, cell wall.
|
|
We do not know of any proteins other than TasA that are likely to be
cleaved in vivo by SipW. However, yqxM could encode an intriguing candidate. The hypothetical yqxM gene product
would possess a plausible signal peptide, and the five N-terminal
residues of the hypothetical mature protein (AFHDI) share four amino
acids with the N terminus of mature TasA (AFNDI). We are currently
testing whether YqxM exists and whether it is processed and translocated.
Under the conditions tested, deletion of SipW has no detectable
consequence for sporulation, indicating that it is not an essential
signal peptidase or that other signal peptidases can substitute when
SipW is absent (consistent with the work of Tjalsma et al.
[32]). Many mutations in genes expressed during
sporulation have only subtle or even undetectable effects under
laboratory conditions. Such genes include spoIIB,
spoVG (21), spoVS (26), and
the majority of the known coat protein genes (27). Because spoIIB and spoVG are likely to play a role during
or immediately after septum formation (21), we constructed
spoIIB
::erm tasA
pAGS08 and
spoVG::Tn917
HU265
tasA
pAGS08 strains (AGS200 and AGS202, respectively).
We did not detect any difference between the tasA
pAGS08 (AGS115) mutant and the double mutants by light microscopy or the
tetrazolium overlay assay (data not shown).
We do not know the role of TasA in vivo. Its broad-spectrum
antibacterial activity may inhibit the growth of competitor bacteria in
nature, a trait that could be useful early in sporulation, as well as
immediately upon germination (15). If so, vegetative B. subtilis cells may be among those competitor bacteria,
since their growth was also inhibited by TasA. The strain of E. coli used for overproduction, BL21(DE3), was also sensitive
to added TasA, but when this strain was used to overproduce TasA, no
inhibition of growth was seen (data not shown). Although we have not
investigated this result in detail, it is likely that the mechanism of
action of TasA requires extracellular application.
Our finding that SipW and at least one of its apparent substrates are
encoded in adjacent genes raises the possibility that the levels of
synthesis of these two proteins are coregulated. Three observations
allow us to speculate that yqxM, sipW, and tasA comprise an operon. First, in preliminary experiments
with strains bearing portions of the yqxM-sipW-tasA region
at the amyE locus, synthesis of TasA required sequences
upstream of yqxM. Second, we could not detect any TasA when
sipW was interrupted by the neomycin resistance gene,
oriented away from tasA. Third, the yqxM and
sipW open reading frames overlap. These results suggest that
the sequences required for the synthesis of TasA are located immediately upstream of the yqxM open reading frame. If the
control of TasA synthesis is largely at the level of transcription, the promoter would probably be in this region as well. Although we do not
know if Spo0A actually binds anywhere within this locus, we have
identified two 7-nucleotide stretches that resemble putative Spo0A
binding sites (2), both of which are upstream of the yqxM open reading frame. It remains to be determined whether
Spo0A binds at these or any other sites in this locus.
In summary, we have identified a sporulation protein, TasA, that is a
component of the spore and is also secreted into the medium. Assembly
of TasA into the spore and export out of the cell both occur
concurrently with the removal of an apparent amino-terminal signal
peptide and depend on sipW. Furthermore, we have identified an antibiotic activity associated with TasA, raising the possibility that TasA inhibits the growth of competitor bacteria during and after sporulation.
 |
ACKNOWLEDGMENTS |
We thank Roberta Carey for giving expert guidance in antibiotic
testing and for selecting and providing animal pathogens, and we thank
Alan Grossman, Richard Losick, and Patrick Stragier for providing
strains. We thank Shawn Little for expert technical assistance. We are
grateful to Roberta Carey, Thomas Gallagher, Alan Grossman, Shawn
Little, David Popham, Orna Resnekov, Linc Sonenshein, Jan Maarten van
Dijl, Chris Webb, and Alan Wolfe for helpful discussions and for
critically reading the manuscript.
This work was supported by Public Health Service grant GM539898 from
the National Institutes of Health and a grant from the Schweppe Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Loyola University Medical Center, 2160 South First Ave., Maywood, IL 60153. Phone: (708) 216-3706. Fax: (708) 216-9574. E-mail: adriks{at}luc.edu.
 |
REFERENCES |
| 1.
|
Bai, U.,
I. Mandic-Mulec, and I. Smith.
1993.
SinI modulates the activity of SinR, a developmental switch protein of Bacillus subtilis, by protein-protein interaction.
Genes Dev.
7:139-148[Abstract/Free Full Text].
|
| 2.
|
Baldus, J. M.,
B. D. Green,
P. Youngman, and C. P. J. Moran.
1994.
Phosphorylation of Bacillus subtilis transcription factor Spo0A stimulates transcription from the spoIIG promoter by enhancing binding to weak 0A boxes.
J. Bacteriol.
176:296-306[Abstract/Free Full Text].
|
| 3.
|
Cutting, S.,
A. Driks,
R. Schmidt,
B. Kunkel, and R. Losick.
1991.
Forespore-specific transcription of a gene in the signal transduction pathway that governs pro- K processing in Bacillus subtilis.
Genes Dev.
5:456-466[Abstract/Free Full Text].
|
| 4.
|
Cutting, S.,
V. Oke,
A. Driks,
R. Losick,
S. Lu, and L. Kroos.
1990.
A forespore checkpoint for mother cell gene expression during development in B. subtilis.
Cell
62:239-250[Medline].
|
| 5.
|
Cutting, S.,
S. Panzer, and R. Losick.
1989.
Regulatory studies on the promoter for a gene governing synthesis and assembly of the spore coat in Bacillus subtilis.
J. Mol. Biol.
207:393-404[Medline].
|
| 6.
|
Cutting, S. M., and P. B. Vander Horn.
1990.
Molecular biological methods for Bacillus.
John Wiley & Sons, Ltd., Chichester, United Kingdom.
|
| 7.
|
Dijkstra, A. J., and W. Keck.
1996.
Peptidoglycan as a barrier to transenvelope transport.
J. Bacteriol.
178:5555-5562[Free Full Text].
|
| 8.
|
Driks, A.,
S. Roels,
B. Beall,
C. P. Moran, Jr., and R. Losick.
1994.
Subcellular localization of proteins involved in the assembly of the spore coat of Bacillus subtilis.
Genes Dev.
8:234-244[Abstract/Free Full Text].
|
| 9.
|
Dubnau, D.
1997.
Binding and transport of transforming DNA by Bacillus subtilis: the role of type-IV pilin-like proteins a review.
Gene
192:191-198[Medline].
|
| 10.
|
Grossman, A. D.
1995.
Genetic networks controlling the initiation of sporulation and the development of genetic competence in Bacillus subtilis.
Annu. Rev. Genet.
29:477-508[Medline].
|
| 11.
|
Harlow, E., and D. Lane.
1988.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 12.
|
Hoch, J. A.
1993.
Regulation of the phosphorelay and the initiation of sporulation in Bacillus subtilis.
Annu. Rev. Microbiol.
47:441-465[Medline].
|
| 13.
|
Irie, R.,
T. Okamoto, and Y. Fujita.
1982.
A germination mutant of Bacillus subtilis deficient in response to glucose.
J. Gen. Appl. Microbiol.
28:345-354.
|
| 14.
|
Itaya, M.,
K. Kondo, and T. Tanaka.
1989.
A neomycin resistance gene cassette selectable in a single copy state in the Bacillus subtilis chromosome.
Nucleic Acids Res.
17:4410[Free Full Text].
|
| 15.
|
Katz, E., and A. L. Demain.
1977.
The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions.
Bacteriol. Rev.
41:449-474[Free Full Text].
|
| 16.
|
King, E. O.,
M. K. Ward, and D. E. Raney.
1954.
Two simple media for the demonstration of pyocyanin and fluorescin.
J. Lab. Clin. Med.
44:301-307[Medline].
|
| 17.
|
Kunst, F.,
N. Ogasawara,
I. Moszer,
A. M. Albertini,
G. Alloni,
V. Azevedo,
M. G. Bertero,
P. Bessieres,
A. Bolotin,
S. Borchert,
R. Borriss,
L. Boursier,
A. Brans,
M. Braun,
S. C. Brignell,
S. Bron,
S. Brouillet,
C. V. Bruschi,
B. Caldwell,
V. Capuano,
N. M. Carter,
S. K. Choi,
J. J. Codani,
I. F. Connerton,
A. Danchin, et al.
1997.
The complete genome sequence of the gram-positive bacterium Bacillus subtilis.
Nature
390:249-256[Medline].
|
| 18.
|
LeDeaux, J. R., and A. D. Grossman.
1995.
Isolation and characterization of kinC, a gene that encodes a sensor kinase homologous to the sporulation sensor kinases KinA and KinB in Bacillus subtilis.
J. Bacteriol.
177:166-175[Abstract/Free Full Text].
|
| 19.
|
Lennette, E. H.,
A. Balows,
W. J. Hausler, Jr., and J. P. Truant (ed.).
1980.
Manual of clinical microbiology, 3rd ed.
American Society for Microbiology, Washington, D.C.
|
| 20.
|
Losick, R., and P. Stragier.
1992.
Crisscross regulation of cell-type-specific gene expression during development in Bacillus subtilis.
Nature
355:601-604[Medline].
|
| 21.
|
Margolis, P. S.,
A. Driks, and R. Losick.
1993.
Sporulation gene spoIIB from Bacillus subtilis.
J. Bacteriol.
175:528-540[Abstract/Free Full Text].
|
| 22.
|
Matsudaira, P.
1987.
Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.
J. Biol. Chem.
262:10035-10038[Abstract/Free Full Text].
|
| 23.
|
Moir, A.
1981.
Germination properties of a spore coat-defective mutant of Bacillus subtilis.
J. Bacteriol.
146:1106-1116[Abstract/Free Full Text].
|
| 24.
|
Nagarajan, V.
1993.
Protein secretion, p. 3-16.
In
A. L. Sonenshein, J. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C.
|
| 25.
|
Pugsley, A. P.
1993.
The complete general secretory pathway in gram-negative bacteria.
Microbiol. Rev.
57:50-108[Abstract/Free Full Text].
|
| 26.
|
Resnekov, O.,
A. Driks, and R. Losick.
1995.
Identification and characterization of sporulation gene spoVS from Bacillus subtilis.
J. Bacteriol.
177:5628-5635[Abstract/Free Full Text].
|
| 27.
|
Ricca, E.,
L. Baccigalupi,
G. Naclerio, and S. Cutting.
1997.
Spore coat differentiation in Bacillus subtilis.
Res. Microbiol.
148:5-9[Medline].
|
| 28.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 29.
|
Sandman, K.,
L. Kroos,
S. Cutting,
P. Youngman, and R. Losick.
1988.
Identification of the promoter for a spore coat protein gene in Bacillus subtilis and studies on the regulation of its induction at a late stage of sporulation.
J. Mol. Biol.
200:461-473[Medline].
|
| 30.
|
Simonen, M., and I. Palva.
1993.
Protein secretion in Bacillus species.
Microbiol. Rev.
57:109-137[Abstract/Free Full Text].
|
| 31.
|
Stragier, P., and R. Losick.
1996.
Molecular genetics of sporulation in Bacillus subtilis.
Annu. Rev. Genet.
30:297-341[Medline].
|
| 32.
|
Tjalsma, H.,
A. Bolhuis,
M. L. van Roosmalen,
T. Wiegert,
W. Schumann,
C. P. Broekhuizen,
W. J. Quax,
G. Venema,
S. Bron, and J. M. van Dijl.
1998.
Functional analysis of the secretory precursor processing machinery of Bacillus subtilis: identification of a eubacterial homolog of archaeal and eukaryotic signal peptidases.
Genes Dev.
12:2318-2331[Abstract/Free Full Text].
|
| 33.
|
Tjalsma, H.,
M. A. Noback,
S. Bron,
G. Venema,
K. Yamane, and J. M. van Dijl.
1997.
Bacillus subtilis contains four closely related type I signal peptidases with overlapping substrate specificities. Constitutive and temporally controlled expression of different sip genes.
J. Biol. Chem.
272:25983-25992[Abstract/Free Full Text].
|
| 34.
|
Youngman, P.,
J. B. Perkins, and R. Losick.
1984.
Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene.
Plasmid
12:1-9[Medline].
|
| 35.
|
Zheng, L.,
W. P. Donovan,
P. C. Fitz-James, and R. Losick.
1988.
Gene encoding a morphogenic protein required in the assembly of the outer coat of the Bacillus subtilis endospore.
Genes Dev.
2:1047-1054[Abstract/Free Full Text].
|
Journal of Bacteriology, March 1999, p. 1664-1672, Vol. 181, No. 5
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vlamakis, H., Aguilar, C., Losick, R., Kolter, R.
(2008). Control of cell fate by the formation of an architecturally complex bacterial community. Genes Dev.
22: 945-953
[Abstract]
[Full Text]
-
Stein, C., Jones, G. W., Chalmers, T., Berry, C.
(2006). Transcriptional Analysis of the Toxin-Coding Plasmid pBtoxis from Bacillus thuringiensis subsp. israelensis.. Appl. Environ. Microbiol.
72: 1771-1776
[Abstract]
[Full Text]
-
Leclere, V., Bechet, M., Adam, A., Guez, J.-S., Wathelet, B., Ongena, M., Thonart, P., Gancel, F., Chollet-Imbert, M., Jacques, P.
(2005). Mycosubtilin Overproduction by Bacillus subtilis BBG100 Enhances the Organism's Antagonistic and Biocontrol Activities. Appl. Environ. Microbiol.
71: 4577-4584
[Abstract]
[Full Text]
-
Branda, S. S., Gonzalez-Pastor, J. E., Dervyn, E., Ehrlich, S. D., Losick, R., Kolter, R.
(2004). Genes Involved in Formation of Structured Multicellular Communities by Bacillus subtilis. J. Bacteriol.
186: 3970-3979
[Abstract]
[Full Text]
-
Tjalsma, H., Antelmann, H., Jongbloed, J. D.H., Braun, P. G., Darmon, E., Dorenbos, R., Dubois, J.-Y. F., Westers, H., Zanen, G., Quax, W. J., Kuipers, O. P., Bron, S., Hecker, M., van Dijl, J. M.
(2004). Proteomics of Protein Secretion by Bacillus subtilis: Separating the "Secrets" of the Secretome. Microbiol. Mol. Biol. Rev.
68: 207-233
[Abstract]
[Full Text]
-
Rhee, K.-J., Sethupathi, P., Driks, A., Lanning, D. K., Knight, K. L.
(2004). Role of Commensal Bacteria in Development of Gut-Associated Lymphoid Tissues and Preimmune Antibody Repertoire. J. Immunol.
172: 1118-1124
[Abstract]
[Full Text]
-
Williams, R. C., Rees, M. L., Jacobs, M. F., Pragai, Z., Thwaite, J. E., Baillie, L. W. J., Emmerson, P. T., Harwood, C. R.
(2003). Production of Bacillus anthracis Protective Antigen Is Dependent on the Extracellular Chaperone, PrsA. J. Biol. Chem.
278: 18056-18062
[Abstract]
[Full Text]
-
Inaoka, T., Takahashi, K., Ohnishi-Kameyama, M., Yoshida, M., Ochi, K.
(2003). Guanine Nucleotides Guanosine 5'-Diphosphate 3'-Diphosphate and GTP Co-operatively Regulate the Production of an Antibiotic Bacilysin in Bacillus subtilis. J. Biol. Chem.
278: 2169-2176
[Abstract]
[Full Text]
-
Berry, C., O'Neil, S., Ben-Dov, E., Jones, A. F., Murphy, L., Quail, M. A., Holden, M. T. G., Harris, D., Zaritsky, A., Parkhill, J.
(2002). Complete Sequence and Organization of pBtoxis, the Toxin-Coding Plasmid of Bacillus thuringiensis subsp. israelensis. Appl. Environ. Microbiol.
68: 5082-5095
[Abstract]
[Full Text]
-
Tamehiro, N., Okamoto-Hosoya, Y., Okamoto, S., Ubukata, M., Hamada, M., Naganawa, H., Ochi, K.
(2002). Bacilysocin, a Novel Phospholipid Antibiotic Produced by Bacillus subtilis 168. Antimicrob. Agents Chemother.
46: 315-320
[Abstract]
[Full Text]
-
van Roosmalen, M. L., Jongbloed, J. D. H., Jong, A. d., van Eerden, J., Venema, G., Bron, S., Maarten van Dijl, J.
(2001). Detergent-independent in vitro activity of a truncated Bacillus signal peptidase. Microbiology
147: 909-917
[Abstract]
[Full Text]
-
Catalano, F. A., Meador-Parton, J., Popham, D. L., Driks, A.
(2001). Amino Acids in the Bacillus subtilis Morphogenetic Protein SpoIVA with Roles in Spore Coat and Cortex Formation. J. Bacteriol.
183: 1645-1654
[Abstract]
[Full Text]
-
Tjalsma, H., Bolhuis, A., Jongbloed, J. D. H., Bron, S., van Dijl, J. M.
(2000). Signal Peptide-Dependent Protein Transport in Bacillus subtilis: a Genome-Based Survey of the Secretome. Microbiol. Mol. Biol. Rev.
64: 515-547
[Abstract]
[Full Text]
-
Ozin, A. J., Henriques, A. O., Yi, H., Moran, C. P. Jr.
(2000). Morphogenetic Proteins SpoVID and SafA Form a Complex during Assembly of the Bacillus subtilis Spore Coat. J. Bacteriol.
182: 1828-1833
[Abstract]
[Full Text]
-
Hirose, I., Sano, K., Shioda, I., Kumano, M., Nakamura, K., Yamane, K.
(2000). Proteome analysis of Bacillus subtilis extracellular proteins: a two-dimensional protein electrophoretic study. Microbiology
146: 65-75
[Abstract]
[Full Text]
-
Bauer, T., Little, S., Stöver, A. G., Driks, A.
(1999). Functional Regions of the Bacillus subtilis Spore Coat Morphogenetic Protein CotE. J. Bacteriol.
181: 7043-7051
[Abstract]
[Full Text]